He added that if a company like Hims refused, it could face an enforcement action from the FDA or a lawsuit on day 61. As of publication, the FDA lists the majority of doses for Novos semaglutide drug (Ozempic, Wegovy, or Rybelsus) as available. Eli Lillys tirzepatide (Mounjaro) is in limited availability across several doses
If you are having side effects at your current dose, do not increase your dosage until those side effects have resolved
10.1111/cns.14497 63 LiaoD.ShangguanD.WuY.ChenY.LiuN.TangJ.et al (2023)
Medical Expense Tax Credit - Canada Revenue Agency Eligible medical expenses, 2026 income thresholds and prescription-drug claim rules
Your licensed provider is the right person to discuss which option is appropriate for your clinical situation and financial circumstances
As pharmacists, it is important that we understand not only the efficacy data, but also patient selection, dose escalation strategies, counseling considerations, and how this potential therapy may fit into an increasingly crowded obesity treatment landscape